Get updates on recent developments, breakthroughs, and announcements.
The study identifies EGFR as a Cathepsin L substrate, revealing how this modification alters cancer signalling.
Marija Grozdanić successfully defended her PhD on the role of cathepsin-mediated EGFR cleavage in cancer signaling.